Case Study:
Mr Jones, a 60 year old African American male, presents to the office for a planned 6
month follow up visit for hyperlipidemia and weight loss. At the previous visit, Mr Jones
was educated on lifestyle recommendations. He reports he has been following dietary
recommendations “as good as he could remember” and exercising as
recommended. He reports some new concerns today. He reports that he has been
experiencing increased fatigue for about the last 10 weeks. He has a health club
membership and attends 3-4 times a week. He walks on the treadmill at least 30
minutes as you directed and lifts weights but he has not lost any weight, in fact he has
gained 7 pounds. He doesn’t understand what he is doing wrong and is requesting more
education and suggestions for weight loss. He reports that exercise makes him even
more hungry and thirsty. He requests further evaluation for his fatigue. He reports he
has to go to the bathroom more often- he is waking up during the night to urinate and
seems to be urinating more frequently during the day. This has been occurring for about
2 months. No other GU symptoms such as painful urination, dribbling or changes in
sexual functionhave been noted.
Current medications: Simvastatin, 10 mg daily, Tylenol 500 mg 2 tabs in AM for knee
pain. Daily multivitamin and turmeric.
PMH: Hyperlipidemia. Right knee OA (for 2 years) Had chicken pox as a child.
Vaccinations up to date. Colonoscopy WNL 7 years- to repeat at 10 years
FH: parents deceased, child alive, well. No siblings.
SH: Divorced. Business executive, job requires frequent travel. Drinks 1-2 beers daily.
Former smoker, quit 5 years ago. No reports illicit drug use. No CBD use.
Allergies: allergic to Bactrim, strawberries, cats and pollen. No latex allergy
Vital signs: BP 119/77; pulse 80, regular; respiration 16, regular
Height 5’9.5”, weight 210 pounds
General: AA male in no acute distress. Alert, oriented and cooperative.
Skin: warm dry and intact. No lesions noted.
HEENT: head normocephalic. Hair thinning distribution across crown. Eyes without
exudate, sclera white. Wears contacts. Tympanic membranes gray and intact with light
reflex noted. Pinna and tragus nontender. Nares patent without exudate. Oropharynx
moist without erythema. Teeth in good repair, no cavities noted. Neck supple. Anterior
and posterior cervical lymph nontender to palpation. No lymphadenopathy. Thyroid
midline, small and firm without palpable masses.
CV: S1 and S2 RRR without murmurs or rubs.
Lungs: Clear to auscultation bilaterally, respirations unlabored.
Abdomen- soft, round, nontender with positive bowel sounds present; no
organomegaly; no abdominal bruits. No CVAT.
Musculoskeletal: full ROM both knees. Nontender to palpation bilaterally. Gait normal.
GU: bladder nontender upon palpation.
Rectal: DRE: prostate not enlarged, rubbery texture, no nodules noted. Guaic negative
Labwork: (fasting labs drawn this morning)
CBC: WBC 6,300/mm3 Hgb 13.8 gm/dl Hct 42% RBC 4.6 million MCV 93 fl MCHC
34 g/dl RDW 13.8%
UA: pH 5, SpGr 1.006, Leukocyte esterase negative, nitrites negative, 1+ glucose;
negative protein; negative ketones
CMP:
Sodium 138
Potassium 4.2
Chloride 100
CO2 29
Glucose 135
BUN 12
Creatinine 0.7
GFR est non-AA 99 mL/min/1.73
GFR est AA 101 mL/min/1.73
Calcium 9.0
Total protein 7.6
Bilirubin, total 0.5
Alkaline phosphatase 72
AST 25
ALT 29
Anion gap 8.10
Bun/Creat 17.7
Hemoglobin A1C: 6.9 %
TSH: 2.30, Free T 4 0.9 ng/dL
Cholesterol: TC 202 mg/dl, LDL 134 mg/dl; VLDL 36 mg/dl; HDL 32mg/dl, Triglycerides
225
EKG: normal sinus rhythm
Purpose
The purpose of this case study assignment is to :
- Analyze provided subjective and objective information to diagnose and develop a management plan for the selected case study patient.
- Apply national diabetes guidelines to a case study patient.
- Apply national guidelines to develop a management plan for all identified secondary diagnosis(es).
Activity Learning Outcomes
Through this assignment, the student will demonstrate the ability to:
- Select appropriate health promotion and disease prevention strategies for patients with or at risk for a glucose metabolism disorder (WO5.1) (CO1,2,3,4,5)
- Demonstrate competence in the evaluation and management of patients with glucose metabolism disorders (WO5.2) (CO1,2,3,4,)
- Develop a management plan for the case study patient based on identified primary, secondary and differential diagnoses. (WO5.3) (CO1,2,3,4,5)
- Apply polypharmacy knowledge to medication reconciliation for selected case study patient.(WO5.4) (CO 6)
Due Date:
Sunday 11:59 p.m. MT at the end of Week 5
This assignment is submitted through Turn It In (TII).* Students are allowed two opportunities to submit. The first Turn It In submission allows the student to view the Turn It In Score and edit the assignment if necessary. The second submission is considered the final submission and will be graded. Any further Turn IT In submissions will not be considered for grading.
*due to the amount of common case study content it is not unusual that the TII may exceed 25%. It is the original work, such as rationale statements and treatment plans that are evaluated for similarity by the faculty.
Total Points Possible: 160
Requirements:
The assignment is a paper, which is to be written in APA format using the provided assignment template. The paper shall not exceed 10 pages, excluding title page and references.
NR601 _week 5 case study paper template_Nov 19.docx
NR 601 case study patient November 19
Review the provided patient visit information. You are provided with the subjective and objective exam findings. As the provider, you are to diagnose the case study patient and develop the management plan for this case study patient. Keep in mind this is a complex patient who has more than one diagnosis, which is common in primary care.
Use the provided case study template for your paper. Review the APA Manual to adhere to APA formatting.
Introduction: briefly discuss the purpose of this paper. (no more than 5 sentences)
Assessment: review the provided case study information.
Identify the primary and secondary diagnosis for the patient. Each diagnosis will include the following information:
- ICD 10 code.
- A brief pathophysiology statement which is no longer that two sentences, paraphrased and includes common signs and symptoms of the diagnosis and proper citation.
- The patient’s pertinent positive and negative findings, including a brief 1-2 sentence statement, which links the subjective and objective findings (including lab data and interpretation).
- An evidence-based rationale statement, which summarizes why the diagnosis was chosen.
- Do not include quotes, paraphrase all scholarly information and provide an in-text citation to your scholarly reference. Use the Reference Guidelines document for information on scholarly references.
Plan: (there are five (5) sections to the management plan)
- List all labs and diagnostic test you would like to order. Each test includes a rationale statement following the listed lab, which includes the diagnosis requiring the test, the purpose of the test and how the test results will contribute to your management plan. Each rationale statement is cited. Include all future follow up labs for each listed diagnosis.
- Medications: Each medication is listed in prescription format. Each prescribed and OTC medication is linked to a specific diagnosis and includes a paraphrased EBP rationale for prescribing.
- Education: section includes personalized detailed education on all five (5) subcategories: diagnosis, each medication purpose and side effects, diet, personalized appropriate exercise recommendations and warning sign for diagnosis and medications if applicable. All education steps are linked to a diagnosis, paraphrased, and include a paraphrased EBP rationale. Review the NR601 Clinical SOAP note guideline for more detailed information.
- Referrals: any recommended referrals are appropriate to the patient diagnosis and current condition, is linked to a specific diagnosis and includes a paraphrased EBP rationale with in text citation. Review the ADA guidelines for specific follow up recommendations.
- Follow up: Follow up includes a specific time, not a time range, to return to PCP office for next scheduled appointment. Includes EBP rationale with in text citation.
Assessment of Comorbidities: in this section students will review the ADA Standards of Medical Care in Diabetes (the guidelines) Assessment of Comorbidities section on comorbidities subsection and choose one listed comorbidity. Students will discuss the significance of and the relationship between the patient’s primary diagnosis and the chosen comorbidity, explaining how one diagnosis affects the other diagnosis. Any recommended screening, diagnostic testing, and referrals are also included.
Medication costs: in this section students will research the costs of all prescribed and OTC monthly medications that you have prescribed and that the patient is currently taking that you would like to continue. Students may use Good Rx, Epocrates or another resource (students may use local pharmacy websites) which provides medication costs. Students will list each medication, the monthly cost of the medication and the reference source. Students will calculate the monthly cost of the case study patient’s prescribed and OTC medications and provide the total costs of the month’s medications. Reflect on the monthly cost of the medications prescribed. Discuss if prescriptions were adjusted due to cost. Discuss if will you use medication pricing resources in future practice
Solution:
Mr. Jones’ Case Study
This paper will discuss both subjective and objective findings to formulate the diagnosis and care plan for Mr. Jones in its key sections of assessment, plan, assessment of comorbidities, and medication costs.
Assessment
Primary Diagnosis: Diabetes Mellitus II (E11.9)
Pathophysiology: Diabetes Mellitus Type 2 (DM2) is a metabolic disease that results from insufficient production of insulin or high insulin resistance, resulting in high levels of glucose within the bloodstream (hyperglycemia). Hyperglycemia leads to symptoms of fatigue, polyuria, nocturia, polydipsia, polyphagia, and unintentional weight loss (American Diabetes Association (ADA), 2019).
Pertinent positive findings: polyuria, nocturia, polydipsia, polyphagia, fatigue, Hemoglobin A1C: 6.9 %, high fasting blood glucose of 136mg/Dl, 1+ glucose in the urine, and high BMI of 30.6. These are key signs and symptoms of DM2, according to ADA (2019).
Pertinent negative findings: Weight gain of 7lbs, nocturia, lack of past diagnosis for diabetes, lifestyle modifications including exercise and diet.
The rationale for the diagnosis: Mr. Jones is experiencing a combination of DM2 signs and symptoms, meeting its diagnostic criteria. The patient’s laboratory results indicating diabetes including high fasting glucose of 136 mg/dl since normal fasting blood sugar is below 100 mg/dl, a high Hemoglobin A1C of 6.9 % as normal Ha1C is between 4 and 5.6%, and +1 glucose in his urine. More so, the patient is positive for key symptoms of symptoms as identified in the positive pertinent. In addition, according to the ADA (2019c), the patient meets the risk factors for DM2 which include being overweight with a BMI of 25kg/m2 and above (Mr. Jones BMI is 30.1) and being 45years old and above (the patient is 60). Further risks are the patient is of African American ancestry and has hyperlipidemia (ADA, 2019)
Secondary Diagnosis: Hypothyroidism (E03.9)
Pathophysiology: Hypothyroidism is a condition characterized by low production of….Please click the icon below to purchase full answer at only $15